Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: May 4, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | A | $963.33 | B | $368.14 | 161.68% | 34.17x | 26.35x | 11.93x | 29.08x | 1.54x | $11.82B | 1.37% | $31.20B | 34.88 | $945.30B | 28.50 |
| GILD | GILEAD SCIENCES INC | A | $131.65 | A | $74.76 | 76.11% | 19.25x | 14.91x | 5.56x | 7.20x | 1.20x | $9.46B | 5.77% | $22.70B | 18.25 | $180.81B | 13.31 |
| CAH | CARDINAL HEALTH INC | A | $195.24 | C | $96.91 | 101.46% | 29.72x | 18.12x | 0.18x | -16.15x | 1.10x | $4.42B | 9.63% | -$2.83B | -12.05 | $50.71B | 15.47 |
| DXCM | DEXCOM INC | A | $61.35 | B | $25.44 | 141.16% | 25.56x | 23.54x | 4.90x | 8.01x | 1.70x | $1.43B | 6.05% | $2.96B | 7.68 | $23.89B | 16.13 |
| THC | TENET HEALTHCARE CORP | A | $183.27 | A | $107.59 | 70.33% | 9.46x | 10.04x | 0.73x | 3.28x | 22.97x | $3.38B | 21.23% | $4.81B | 55.46 | $26.03B | 6.63 |
| JLL | JONES LANG LASALLE INC | A | $315.24 | B | $200.29 | 57.39% | 16.62x | 13.83x | 0.55x | 2.00x | 1.11x | $970.70M | 6.57% | $7.31B | 156.01 | $18.16B | 12.54 |
| LEVI | LEVI STRAUSS & CO | A | $22.28 | B | $11.05 | 101.62% | 14.19x | 14.56x | 1.34x | 3.88x | 3.01x | $474.40M | 5.46% | $2.21B | 5.66 | $10.17B | 9.88 |
| BCO | BRINKS CO | A | $107.52 | B | $102.80 | 4.59% | 22.73x | 11.58x | 0.86x | 15.93x | 0.48x | $436.40M | 9.62% | $277.70M | 6.58 | $6.68B | 7.60 |
| AMRX | AMNEAL PHARMACEUTICALS INC | A | $12.83 | B | $10.44 | 22.94% | 55.78x | 12.71x | 1.33x | -57.02x | 0.48x | $243.24M | 6.05% | -$70.79M | -0.23 | $6.41B | 11.71 |
| KTB | KONTOOR BRANDS INC | A | $72.20 | A | $61.81 | 16.81% | 17.61x | 11.19x | 1.27x | 7.06x | 0.63x | $436.57M | 10.89% | $564.87M | 10.18 | $5.17B | 12.66 |
| LIVN | LIVANOVA PLC | A | $61.00 | C | N/A | N/A | -13.71x | 14.20x | 2.40x | 2.78x | N/A | $173.29M | 5.21% | $1.20B | 22.00 | $3.13B | -27.93 |
| DBD | DIEBOLD NIXDORF INC | A | $77.86 | B | $88.53 | -12.05% | 26.30x | 14.02x | 0.71x | 2.64x | 0.37x | $253.60M | 9.28% | $1.02B | 29.14 | $3.26B | 9.26 |
| VCYT | VERACYTE INC | A | $33.09 | B | $9.95 | 232.55% | 39.39x | 36.18x | 5.03x | 2.01x | 2.11x | $126.63M | 4.87% | $1.31B | 16.67 | $2.30B | 24.89 |
| ATRO | ASTRONICS CORP | A | $71.21 | C | $56.62 | 25.77% | 85.80x | 26.42x | 2.95x | 18.14x | 0.47x | $43.12M | 1.70% | $140.07M | 3.93 | $2.90B | 40.02 |
| HLIO | HELIOS TECHNOLOGIES INC | A | $66.84 | C | $25.84 | 158.69% | 45.78x | 24.90x | 2.64x | 2.38x | 1.29x | $100.30M | 4.52% | $931.50M | 28.06 | $2.51B | 17.02 |
| HCI | HCI GROUP INC | A | $152.30 | B | N/A | N/A | 6.20x | 8.98x | 2.20x | 1.90x | N/A | $440.82M | 22.28% | $1.04B | 80.13 | $832.68M | 1.94 |
| INVA | INNOVIVA INC | A | $23.11 | A | N/A | N/A | 5.75x | 11.84x | 3.79x | 1.46x | N/A | $195.81M | 12.57% | $1.17B | 17.40 | $1.42B | 3.70 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | A | $50.80 | B | $107.15 | -52.59% | 43.05x | 10.61x | 1.82x | 3.43x | 0.17x | $107.80M | 7.72% | $379.20M | 13.79 | $1.46B | 11.92 |
| PHAR | PHARMING GROUP NV | A | $16.98 | B | N/A | N/A | 361.28x | N/A | 2.72x | 3.70x | N/A | $62.74M | 5.27% | $322.21M | 4.59 | $1.16B | 40.79 |
| INR | INFINITY NATURAL RESOURCES INC | A | $16.19 | C | $29.97 | -45.97% | 17.99x | 4.48x | 0.70x | 3.34x | 0.22x | -$168.38M | -67.61% | $307.14M | 19.97 | $1.18B | 8.87 |
| MNTN | MNTN INC | A | $10.14 | B | N/A | N/A | -78.00x | 10.92x | 1.78x | 2.45x | N/A | $43.97M | 8.52% | $305.74M | 6.01 | $538.91M | -56.05 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | A | $16.83 | B | N/A | N/A | N/A | 0.40x | 0.76x | 7.35x | N/A | $151.30M | 24.09% | $85.46M | 2.29 | $862.70M | 5.10 |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | $26.66 | B | $7.59 | 251.42% | 24.69x | 23.34x | 1.00x | 2.89x | 5.27x | $28.84M | 6.01% | $161.55M | 8.97 | $391.76M | 8.20 |
| ASMB | ASSEMBLY BIOSCIENCES INC | A | $27.37 | C | N/A | N/A | -49.76x | -8.97x | N/A | 2.10x | N/A | -$41.16M | -13.41% | $206.75M | 18.44 | $378.34M | -63.13 |
| PKOH | PARK OHIO HOLDINGS CORP | A | $28.54 | B | $28.49 | 0.19% | 16.50x | 9.04x | 0.25x | 1.08x | 0.51x | $1.00M | 0.25% | $380.90M | 27.60 | $1.04B | 9.68 |
| ELMD | ELECTROMED INC | A | $25.60 | B | $7.94 | 222.24% | 23.93x | 22.90x | 3.07x | 4.66x | 4.10x | $8.25M | 3.90% | $45.44M | 5.49 | $198.06M | 15.08 |
| INFU | INFUSYSTEM HOLDINGS INC | A | $10.37 | C | $4.55 | 128.03% | 32.41x | 24.45x | 1.49x | 3.66x | 1.27x | $19.03M | 8.88% | $57.33M | 2.78 | $229.50M | 9.10 |
| PMTS | CPI CARD GROUP INC | A | $17.38 | A | $27.76 | -37.40% | 13.17x | 8.45x | 0.36x | -11.49x | 0.29x | $41.33M | 21.00% | -$17.33M | -1.53 | $464.15M | 6.06 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.